Zou, L.-Q., Zhou, H.-Y., Zhuang, Y., van Hartevelt, T. J., Lui, S. S. Y., Cheung, E. F. C., Møller, A., Kringelbach, M. L. & Chan, R. C. K. (2018). Neural responses during the anticipation and receipt of olfactory reward and punishment in human. Neuropsychologia, 111, 172-179. https://doi.org/10.1016/j.neuropsychologia.2018.02.003

Zhang, Z., Jiang, R., Zhang, C., Williams, B., Jiang, Z., Li, C. T., Chazot, P., Pavese, N., Bouridane, A. & Beghdadi, A. (2022). Robust Brain Age Estimation Based on sMRI via Nonlinear Age-Adaptive Ensemble Learning. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 30, 2146-2156. https://doi.org/10.1109/TNSRE.2022.3190467

Yousif, N., Mace, M., Pavese, N., Borisyuk, R., Nandi, D. & Bain, P. (2017). A Network Model of Local Field Potential Activity in Essential Tremor and the Impact of Deep Brain Stimulation. PLOS Computational Biology, 13(1), e1005326. Article e1005326. https://doi.org/10.1371/journal.pcbi.1005326

Yousif, N., Pavese, N., Naushahi, M. J., Nandi, D. & Bain, P. G. (2014). Reversing the polarity of bipolar stimulation in deep brain stimulation for essential tremor: a theoretical explanation for a useful clinical intervention. Neurocase, 20(1), 10-7. https://doi.org/10.1080/13554794.2012.713495

Yousif, N., Borisyuk, R., Pavese, N., Nandi, D. & Bain, P. (2012). Spatiotemporal visualization of deep brain stimulation-induced effects in the subthalamic nucleus. The European journal of neuroscience, 36(2), 2252-9. https://doi.org/10.1111/j.1460-9568.2012.08086.x

Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P. F., O'Brien, J. T., Robbins, T. W., Wesnes, K., Brooks, D. J., Barker, R. A. ... ICICLE-PD Study Group (2014). Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study. Neurology, 82(4), 308-16. https://doi.org/10.1212/WNL.0000000000000066

Xu, Z., Arbizu, J. & Pavese, N. (2018). PET Molecular Imaging in Atypical Parkinsonism. International Review of Neurobiology, 142, 3-36. https://doi.org/10.1016/bs.irn.2018.09.001

Xu, Z., Anderson, K., Lawson, R., Brooks, D. J. & Pavese, N. (2018). Progression of sleep disorders spectrum in Parkinson's Disease: A 5 year clinical longitudinal study. Movement Disorders, 33, S761-S762.

Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R., Brooks, D. & Pavese, N. (2021). Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study. Journal of Neurology, 268(1), 312-320. https://doi.org/10.1007/s00415-020-10140-x

Xu, Z., Anderson, K. N. & Pavese, N. (2022). Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 22(10), 635-655. https://doi.org/10.1007/s11910-022-01223-5

Xing, Y., Sapuan, A. H., Martín-Bastida, A., Naidu, S., Tench, C., Evans, J., Sare, G., Schwarz, S. T., Al-bachari, S., Parkes, L. M., Kanavou, S., Raw, J., Silverdale, M., Bajaj, N., Pavese, N., Burn, D., Piccini, P., Grosset, D. G. & Auer, D. P. (2022). Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Movement Disorders, 37(5), 1028-1039. https://doi.org/10.1002/mds.28934

Wu, K., O'Keeffe, D., Politis, M., O'Keeffe, G. C., Robbins, T. W., Bose, S. K., Brooks, D. J., Piccini, P. & Barker, R. A. (2012). The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. Brain, 135(Pt 8), 2449-57. https://doi.org/10.1093/brain/aws157

Woitalla, D., Dunac, A., Safavi, A., Ceravolo, M. G., Gomez Esteban, J. C., Pavese, N., Asgharnejad, M., Joeres, L., Schuller, J. C. & Chaudhuri, K. R. (2018). A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease. Expert Opinion on Pharmacotherapy, 19(9), 937-945. https://doi.org/10.1080/14656566.2018.1480721

Winterdahl, M., Audrain, H., Landau, A. M., Smith, D. F., Bonaventure, P., Shoblock, J. R., Carruthers, N., Swanson, D. & Bender, D. (2014). PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. Journal of Nuclear Medicine, 55(4), 635-9. https://doi.org/10.2967/jnumed.113.125351

Winterdahl, M., Noer, O., Orlowski, D., Schacht, A. C., Jakobsen, S., Alstrup, A. K. O., Gjedde, A. & Landau, A. (2019). Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain. Scientific Reports, 9(1), Article 16918. https://doi.org/10.1038/s41598-019-53430-9

Wills, A. J., Thompson, P. D., Findley, L. J. & Brooks, D. J. (1996). A positron emission tomography study of primary orthostatic tremor. Neurology, 46(3), 747-752. https://doi.org/10.1212/WNL.46.3.747

Williams, T. M., Davies, S. J. C., Taylor, L. G., Daglish, M. R. C., Hammers, A., Brooks, D. J., Nutt, D. J. & Lingford-Hughes, A. (2009). Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [¹¹C]diprenorphine PET study. European Neuropsychopharmacology, 19(10), 740-748. https://doi.org/10.1016/j.euroneuro.2009.06.007

Williams, T. M., Daglish, M. R. C., Lingford-Hughes, A., Taylor, L. G., Hammers, A., Brooks, D. J., Grasby, P., Myles, J. S. & Nutt, D. J. (2007). Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study. British Journal of Psychiatry, 191(JULY), 63-69. https://doi.org/10.1192/bjp.bp.106.031120

Williams, S. C. R., Simmons, A., Samuel, M., Brammer, M. J., Bullmore, E. T., Goldstein, L. H., Andrew, C. M., Andrews, C., Glover, A., Allin, M. B., Brooks, D. J. & Leigh, P. N. (1997). A simple FMRI paradigm for mapping the major components of the human motor system. NeuroImage, 5(4 PART II).

Wilkinson, L., Tai, Y. F., Lin, C. S., Lagnado, D. A., Brooks, D. J., Piccini, P. & Jahanshahi, M. (2014). Probabilistic classification learning with corrective feedback is associated with in vivo striatal dopamine release in the ventral striatum, while learning without feedback is not. Human Brain Mapping, 35(10), 5106-15. https://doi.org/10.1002/hbm.22536

Wicks, P., Turner, M. R., Abrahams, S., Hammers, A., Brooks, D. J., Leigh, P. N. & Goldstein, L. H. (2008). Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (¹¹C)-flumazenil PET study. Amyotrophic Lateral Sclerosis, 9(1), 43-49. https://doi.org/10.1080/17482960701737716

Whone, A. L., Von Spiczak, S., Edwards, M., Valente, E. M., Hammers, A., Bhatia, K. P. & Brooks, D. J. (2004). Opioid binding in DYT1 primary torsion dystonia: An ₁₁C-diprenorphine PET study. Movement Disorders, 19(12), 1498-1503. https://doi.org/10.1002/mds.20238

Whone, A. L., Bailey, D. L., Remy, P., Pavese, N. & Brooks, D. J. (2004). A technique for standardized central analysis of 6-¹⁸F-fluoro-L- DOPA PET data from a multicenter study. Journal of Nuclear Medicine, 45(7), 1135-1145.

Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., Poewe, W. H., Hauser, R. A. & Brooks, D. J. (2003). Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Annals of Neurology, 54(1), 93-101. https://doi.org/10.1002/ana.10609

Whone, A. L., Moore, R. Y., Piccini, P. P. & Brooks, D. J. (2003). Plasticity of the nigropallidal pathway in Parkinson's disease. Annals of Neurology, 53(2), 206-213. https://doi.org/10.1002/ana.10427

White, R. P., Deane, C., Hindley, C., Bloomfield, P. M., Cunningham, V. J., Vallance, P., Brooks, D. J. & Markus, H. S. (2000). The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. Journal of the Neurological Sciences, 178(1), 23-28. https://doi.org/10.1016/S0022-510X(00)00357-9

White, R. P., Hindley, C., Bloomfield, P. M., Cunningham, V. J., Vallance, P., Brooks, D. J. & Markus, H. S. (1999). The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: A PET study. Journal of Cerebral Blood Flow and Metabolism, 19(6), 673-678. https://doi.org/10.1097/00004647-199906000-00011

Wenning, G. K., Tison, F., Seppi, K., Sampiao, C., Diem, A., Yekhlef, F., Ghorayeb, I., Ory, F., Galitzky, M., Scaravilli, T., Bozi, M., Colosimo, C., Gilman, S., Shults, C. W., Quinn, N. P., Rascol, O., Poewe, W., Dupont, E., Ostergaard, K. ... Bergquist, J. (2004). Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Movement Disorders, 19(12), 1391-1402. https://doi.org/10.1002/mds.20255

Wenning, G. K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Brown, R., Gustavii, B., Hagell, P., Jahanshahi, M., Sawle, G., Björklund, A., Brooks, D. J., Marsden, C. D., Quinn, N. P. & Lindvall, O. (1997). Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Annals of Neurology, 42(1), 95-107. https://doi.org/10.1002/ana.410420115

Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., Eberling, J., Espay, A. J., Foster, E. D., Leverenz, J. B., Litvan, I., Richard, I., Troyer, M. D., Hawkins, K. A., Marek, K. ... Hogarth, P. (2015). Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disorders, 30(7), 919-927. https://doi.org/10.1002/mds.26170

Weeks, R. A., Cunningham, V. J., Piccini, P., Waters, S., Harding, A. E. & Brooks, D. J. (1997). ¹¹C-diprenorphine binding in Huntington's disease: A comparison of region of interest analysis with statistical parametric mapping. Journal of Cerebral Blood Flow and Metabolism, 17(9), 943-949. https://doi.org/10.1097/00004647-199709000-00003

Weeks, R. A., Ceballos-Baumann, A., Piccini, P., Boecker, H., Harding, A. E. & Brooks, D. J. (1997). Cortical control of movement in Huntington's disease. A PET activation study. Brain, 120(9), 1569-1578. https://doi.org/10.1093/brain/120.9.1569

Weeks, R. A., Turjanski, N. & Brooks, D. J. (1996). Tourette's syndrome: A disorder of cingulate and orbitofrontal function? QJM - Monthly Journal of the Association of Physicians, 89(6), 401-408.

Weeks, R. A., Piccini, P., Harding, A. E. & Brooks, D. J. (1996). Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Annals of Neurology, 40(1), 49-54. https://doi.org/10.1002/ana.410400110

Weeks, R. A., Scott, J., Brooks, D. J., Hodgson, H., Cohen, J. & Lynn, W. A. (1996). Cerebral Whipple's disease. British Medical Journal, 312(7027), 371-373.

Watson, B. J., Taylor, L. G., Reid, A. G., Wilson, S. J., Stokes, P. R., Brooks, D. J., Myers, J. F., Turkheimer, F. E., Nutt, D. J. & Lingford-Hughes, A. R. (2014). Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET. Addiction Biology (Online), 19(6), 1032-40. https://doi.org/10.1111/adb.12073

Wang, Y., Zou, L., Xie, W., Yang, Z., Zhu, X., Cheung, EFC., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2019). Altered functional connectivity of the default mode network in patients with schizo-obsessive comorbidity: A comparison between schizophrenia and obsessive-compulsive disorder. Schizophrenia Bulletin, 45(1), 199-210. https://doi.org/10.1093/schbul/sbx194

Wang, Y.-M., Zou, L.-Q., Xie, W.-L., Yang, Z.-Y., Zhu, X.-Z., Cheung, E. F. C., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2018). Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity. Psychiatry Research, 276, 65-72. https://doi.org/10.1016/j.pscychresns.2018.03.009

Wang, Y. M., Cai, X. L., Zhang, R. T., Wang, Y., Madsen, K. H., Sørensen, T. A., Møller, A., Cheung, E. F. C. & Chan, R. C. K. (2019). Searchlight classification based on Amplitude of Low Frequency Fluctuation and functional connectivity in individuals with obsessive-compulsive symptoms. Cognitive Neuropsychiatry, 24(5), 322-334. https://doi.org/10.1080/13546805.2019.1658575

Wang, Y. M., Yang, Z. Y., Cai, X. L., Zhou, H. Y., Zhang, R. T., Yang, H. X., Liang, Y. S., Zhu, X. Z., Madsen, K. H., Sørensen, T. A., Møller, A., Wang, Z., Cheung, E. F. C. & Chan, R. C. K. (2020). Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography. Schizophrenia Bulletin, 46(2), 442-453. https://doi.org/10.1093/schbul/sbz073

Vuust, P., Josefsen, L. G., Hansen, N. C., Ramsgaard, S., Møller, A. & Linnet, J. (2010). Personality influences career choice:  Sensation seeking in professional musicians. Music Education Research, 12(2), 219. https://doi.org/10.1080/14613801003746584

Von Spiczak, S., Whone, A. L., Hammers, A., Asselin, M. C., Turkheimer, F., Tings, T., Happe, S., Paulus, W., Trenkwalder, C. & Brooks, D. J. (2005). The role of opioids in restless legs syndrome: An [¹¹C] diprenorphine PET study. Brain, 128(4), 906-917. https://doi.org/10.1093/brain/awh441

Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., Ikonomovic, M. D., Ishii, K., Jack, C. R., Jagust, W. J., Johnson, K. A., Koeppe, R. A., Lowe, V. J., Masters, C. L., Montine, T. J., Morris, J. C., Nordberg, A., Petersen, R. C., Reiman, E. M. ... Drzezga, A. (2012). Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 39(2), 209-19. https://doi.org/10.1007/s00259-011-2045-0

Vidailhet, M., Stocchi, F., Rothwell, J. C., Thompson, P. D., Day, B. L., Brooks, D. J. & Marsden, C. D. (1993). The bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease. Neurology, 43(9), 1784-1788.

Vibholm, A. K., Landau, A., Alstrup, A. K. O., Jacobsen, J., Hansen, K. V., Munk, O. L., Dietz, M., Orlowski, D., Sorensen, J. C. & Brooks, D. J. (2020). Activation of NMDA receptor ion channels by deep brain stimulation in the pig visualised with [18F]GE-179 PET. Brain Stimulation, 13(4), 1071-1078. https://doi.org/10.1016/j.brs.2020.03.019

Vibholm, A. K., Landau, A. M., Møller, A., Jacobsen, J., Vang, K., Munk, O. L., Orlowski, D., Sorensen, J. C. H. & Brooks, D. J. (2021). NMDA receptor ion channel activation detected in vivo with [¹⁸F]GE-179 PET after electrical stimulation of rat hippocampus. Journal of Cerebral Blood Flow and Metabolism, 41(6), 1301-1312. https://doi.org/10.1177/0271678X20954928

Vibholm, A. K., Dietz, M. J., Beniczky, S., Christensen, J., Højlund, A., Jacobsen, J., Bender, D., Møller, A. & Brooks, D. J. (2021). Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [¹⁸F]GE-179 positron emission tomography. Epilepsia, 62(12), 2899-2908. https://doi.org/10.1111/epi.17074

Ventimiglia, R., Jones, B. E. & Møller, A. (1995). A quantitative method for morphometric analysis in neuronal cell culture: unbiased estimation of neuron area and number of branch points. Journal of Neuroscience Methods, 57, 63-66.

Venkataraman, A. V., Mansur, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D., Gunn, R. N., Matthews, P. M., Rabiner, E. A. & MINDMAPS Consortium (2019). Evaluation of mitochondrial and synaptic function in Alzheimer's disease (AD): a [F-18]BCPP-EF, [C-11]SA4503 and [C-11]UCB-J PET study. Journal of Cerebral Blood Flow and Metabolism, 39(Suppl. 1), 121-122.

Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D. J., Martarello, L., Comley, R. A., Chen, L., Schwarz, A. J., Hargreaves, R., Gunn, R. N., Rabiner, E. A. & Matthews, P. M. (2022). Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease. Science Translational Medicine, 14(658), Article eabk1051. https://doi.org/10.1126/scitranslmed.abk1051

Varning, T., Christophersen, P., Møller, A., Peters, D., Axelsson, O. & Nielsen, E. Ø. (1996). Synthesis and biological actitivy of the neuronal calcium channel blocker 2-amino-1-(2,5-dimethoxyphenyl)-5-trifluoromethyl benzimidazole (NS-649). Bioorganic & Medicinal Chemistry Letters, 6, 245-248.

Varming, T., Sager, T. N., Mathiesen, C., Johansen, T. H., Møller, A., Wätjen, F. & Drejer, J. (2001). Optimazation of isatine oximes as neuroprotective AMPA receptor antagonist: In vitro and in vivo evaluation of SPD 502. In: Excitatory amino acids: Ten years after. IOS press.

Varley, J., Brooks, D. J. & Edison, P. (2015). Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. Alzheimer's & Dementia, 11(9), 1110-1120. https://doi.org/10.1016/j.jalz.2014.08.105

Van Hartevelt, T. J., Cabral, J., Deco, G., Møller, A., Green, A. L., Aziz, T. Z. & Kringelbach, M. L. (2014). Neural plasticity in human brain connectivity: The effects of long term deep brain stimulation of the subthalamic nucleus in Parkinson's disease. P L o S One, 9(1), Article e86496. https://doi.org/10.1371/journal.pone.0086496

van Hartevelt, T. J., Cabral, J., Møller, A., FitzGerald, J. J., Green, A. L., Aziz, T. Z., Deco, G. & Kringelbach, M. L. (2015). Evidence from a rare case study for Hebbian-like changes in structural connectivity induced by long-term deep brain stimulation. Frontiers in Behavioral Neuroscience, 9, 167. https://doi.org/10.3389/fnbeh.2015.00167

van Eimeren, T., Antonini, A., Berg, D., Bohnen, N., Ceravolo, R., Drzezga, A., Höglinger, G. U., Higuchi, M., Lehericy, S., Lewis, S., Monchi, O., Nestor, P., Ondrus, M., Pavese, N., Peralta, M. C., Piccini, P., Pineda-Pardo, J. Á., Rektorová, I., Rodríguez-Oroz, M. ... MDS Neuroimaging Study Group and the JPND Working Group ASAP-SynTau (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, 301-309. https://doi.org/10.1016/j.dadm.2019.01.011

Vandenberghe, R., Nelissen, N., Salmon, E., Ivanoiu, A., Hasselbalch, S., Andersen, A., Korner, A., Minthon, L., Brooks, D. J., Van Laere, K. & Dupont, P. (2013). Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI. NeuroImage, 64, 517-25. https://doi.org/10.1016/j.neuroimage.2012.09.015

Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., Minthon, L., Garraux, G., Nelissen, N., Bormans, G., Buckley, C., Owenius, R., Thurfjell, L., Farrar, G. & Brooks, D. J. (2010). ¹⁸F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment a phase 2 trial. Annals of Neurology, 68(3), 319-329. https://doi.org/10.1002/ana.22068

Turner, M. R., Hammers, A., Allsop, J., Al-Chalabi, A., Shaw, C., Brooks, D. J., Leigh, N. P. & Andersen, P. (2007). Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 8(6), 343-347. https://doi.org/10.1080/17482960701538734

Turner, M. R., Rabiner, E. A., Al-Chalabi, A., Shaw, C. E., Brooks, D. J., Leigh, P. N. & Andersen, P. M. (2007). Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. Neurology, 68(15), 1233-1235. https://doi.org/10.1212/01.wnl.0000259083.31837.64

Turner, M. R., Osei-Lah, A. D., Hammers, A., Al-Chalabi, A., Shaw, C. E., Andersen, P. M., Brooks, D. J., Leigh, P. N. & Mills, K. R. (2005). Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. Journal of Neurology, Neurosurgery & Psychiatry, 76(9), 1279-1285. https://doi.org/10.1136/jnnp.2004.054429

Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E., Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2005). Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [¹¹C]flumazenil PET. Brain, 128(6), 1323-1329. https://doi.org/10.1093/brain/awh509

Turner, M. R., Rabiner, E. A., Hammers, A., Al-Chalabi, A., Grasby, P. M., Shaw, C. E., Brooks, D. J. & Leigh, P. N. (2005). [¹¹C]-WAY100635 PET demonstrates marked 5-HT_1A receptor changes in sporadic ALS. Brain, 128(4), 896-905. https://doi.org/10.1093/brain/awh428

Turner, M. R., Gerhard, A., Al-Chalabi, A., Shaw, C. E., Hughes, R. A. C., Banati, R. B., Brooks, D. J. & Leigh, P. N. (2005). Mills' and other isolated upper motor neurone syndromes: In vivo study with ¹¹C-(R)-PK11195 PET. Journal of Neurology, Neurosurgery & Psychiatry, 76(6), 871-874. https://doi.org/10.1136/jnnp.2004.047902

Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N. & Banati, R. B. (2004). Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [¹¹C](R)-PK11195 positron emission tomography study. Neurobiology of Disease, 15(3), 601-609. https://doi.org/10.1016/j.nbd.2003.12.012

Turkheimer, F. E., Anderson, A. N., Boussion, N., Pavese, N., Brooks, D. J. & Visvikis, D. (2007). PET image denoising through a synergistic wavelet transform based multi-resolution analysis of structural and functional datasets. Journal of Cerebral Blood Flow and Metabolism, 27(SUPPL. 1).

Turkheimer, F. E., Edison, P., Pavese, N., Roncaroli, F., Anderson, A. N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y. F. & Brooks, D. J. (2007). Reference and target region modeling of [11C]-(R)-PK11195 brain studies. Journal of Nuclear Medicine, 48(1), 158-167.

Turkheimer, F. E., Boussion, N., Anderson, A. N., Pavese, N., Piccini, P. & Visvikis, D. (2008). PET image denoising using a synergistic multiresolution analysis of structural (MRI/CT) and functional datasets. Journal of Nuclear Medicine, 49(4), 657-666. https://doi.org/10.2967/jnumed.107.041871

Turjanski, N., Lees, A. J. & Brooks, D. J. (1999). Striatal dopaminergic function in restless legs syndrome: ¹⁸F-dopa and ¹¹C-raclopride PET studies. Neurology, 52(5), 932-937.

Turjanski, N., Lees, A. J. & Brooks, D. J. (1997). In vivo studies on striatal dopamine D₁ and D₂ site binding in L- dopa-treated Parkinson's disease patients with and without dyskinesias. Neurology, 49(3), 717-723. https://doi.org/10.1212/WNL.49.3.717

Turjanski, N., Lees, A. J. & Brooks, D. J. (1997). Dopaminergic function in patients with posttraumatic parkinsonism: An ¹⁸F-dopa PET study. Neurology, 49(1), 183-189. https://doi.org/10.1212/WNL.49.1.183

Turjanski, N., Pentland, B., Lees, A. J. & Brooks, D. J. (1997). Parkinsonism associated with acute intracranial hematomas: An [¹⁸F]dopa positron-emission tomography study. Movement Disorders, 12(6), 1035-1038. https://doi.org/10.1002/mds.870120630

Turjanski, N., Weeks, R., Dolan, R., Dolan, R., Harding, A. E. & Brooks, D. J. (1995). Striatal D1and D2receptor binding in patients with huntington's disease and other choreas A PET study. Brain, 118(3), 689-696. https://doi.org/10.1093/brain/118.3.689

Turjanski, N., Sawle, G. V., Playford, E. D., Weeks, R., Lammerstma, A. A., Lees, A. J. & Brooks, D. J. (1994). PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. Journal of Neurology Neurosurgery and Psychiatry, 57(6), 688-692. https://doi.org/10.1136/jnnp.57.6.688

Turjanski, N. & Brooks, D. J. (1997). PET and the investigation of dementia in the parkinsonian patient. Journal of Neural Transmission, Supplement, (51), 37-48.

Torup, L., Møller, A., Sager, T. N. & Diemer, N. H. (2000). Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting. European Journal of Pharmacology, 395, 137-141.

Tomasi, G., Edison, P., Bertoldo, A., Roncaroli, F., Singh, P., Gerhard, A., Cobelli, C., Brooks, D. J. & Turkheimer, F. E. (2008). Novel reference region model reveals increased microglial and reduced vascular binding of11C-(R)-PK11195 in patients with Alzheimer's disease. Journal of Nuclear Medicine, 49(8), 1249-1256. https://doi.org/10.2967/jnumed.108.050583

Tomasi, G., Bertoldo, A., Edison, P., Roncaroli, F., Pavese, N., Hammers, A., Yen, F. T., Cobelli, C., Brooks, D. J., Gerhard, A. & Turkheimer, F. (2007). Increased binding potential of [11C]PK11195 in Alzheimer disease using a new SRTM accounting for vascular binding. Journal of Cerebral Blood Flow and Metabolism, 27(SUPPL. 1).

Tomasi, G., Bertoldo, A., Cobelli, C., Pavese, N., Tai, Y. F., Hammers, A. & Turkheimer, F. E. (2011). Global-two-stage filtering of clinical PET parametric maps: Application to [11C]-(R)-PK11195. NeuroImage, 55(3), 942-953. https://doi.org/10.1016/j.neuroimage.2010.12.056

Tilley, B. S., Smith, C., Pavese, N. & Attems, J. (2019). Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration. BMJ Case Reports, 12(3), Article e228305. https://doi.org/10.1136/bcr-2018-228305

Thurfjell, L., Lötjönen, J., Lundqvist, R., Koikkalainen, J., Soininen, H., Waldemar, G., Brooks, D. J. & Vandenberghe, R. (2012). Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neurodegenerative Diseases, 10(1-4), 246-9. https://doi.org/10.1159/000335381

Thomsen, K. R., Lou, H. O. C., Jønsson, M., Hyam, J. A., Holland, P., Parsons, C., Young, K. S., Møller, A., Stein, A., Green, A. L., Kringelbach, M. L. & Aziz, T. Z. (2011). Impact of Emotion on Consciousness: Positive Stimuli Enhance Conscious Reportability. P L o S One, 6(4), 1-8. https://doi.org/10.1371/journal.pone.0018686

Thomsen, M. B., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H., Simonsen, M., Wegener, G., Landau, A. M. & Tasker, A. (2016). Neonatal domoic acid alters in vivo binding of [(11)C]yohimbine to α2-adrenoceptors in adult rat brain. Psychopharmacology, 233(21), 3779-3785. https://doi.org/10.1007/s00213-016-4416-5

Thomsen, M. B., Schacht, A. C., Alstrup, A. K. O., Jacobsen, J., Lillethorup, T. P., Bærentzen, S. L., Noer, O., Orlowski, D., Elfving, B., Müller, H. K., Brooks, D. J. & Landau, A. M. (2020). Preclinical PET Studies of [¹¹C]UCB-J Binding in Minipig Brain. Molecular Imaging and Biology, 22(5), 1290-1300. https://doi.org/10.1007/s11307-020-01506-8

Thomsen, M., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M. I. T., Romero-Ramos, M., Brooks, D. J. & Landau, A. (2021). In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Journal of Cerebral Blood Flow and Metabolism, 41(4), 819-830. https://doi.org/10.1177/0271678X20931140

Thomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M. & Romero-Ramos, M. (2021). PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease, 149, Article 105229. https://doi.org/10.1016/j.nbd.2020.105229

Thomsen, M. B., Landau, A. M., Bender, D. & Cumming, P. (2023). Autoradiographic characterization of [¹⁸F]PSMA-1007 binding in rat brain. Synapse, 77(6), Article e22280. https://doi.org/10.1002/syn.22280

Thomas, D. G. T., Beaney, R. P. & Brooks, D. J. (1984). Positron emission tomography in the study of cerebral tumours. Neurosurgical Review, 7(4), 253-258. https://doi.org/10.1007/BF01892906

Thobois, S., Hotton, G. R., Pinto, S., Wilkinson, L., Limousin-Dowsey, P., Brooks, D. J. & Jahanshahi, M. (2007). STN stimulation alters pallidal-frontal coupling during response selection under competition. Journal of Cerebral Blood Flow and Metabolism, 27(6), 1173-1184. https://doi.org/10.1038/sj.jcbfm.9600425

Thevathasan, W., Debu, B., Aziz, T., Bloem, B. R., Blahak, C., Butson, C., Czernecki, V., Foltynie, T., Fraix, V., Grabli, D., Joint, C., Lozano, A. M., Okun, M. S., Ostrem, J., Pavese, N., Schrader, C., Tai, C.-H., Krauss, J. K., Moro, E. & Movement Disorders Society PPN DBS Working Groupin collaboration with the World Society for Stereotactic and Functional Neurosurgery (2018). Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review. Movement Disorders, 33(1), 10-20. https://doi.org/10.1002/mds.27098

Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V., Lauritsen, J., Pavese, N. & Romero-Ramos, M. (2022). Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies. Journal of Parkinson's Disease, 12(s1), S149-S163. https://doi.org/10.3233/JPD-223245

Terkelsen, M. H., Hvingelby, V. & Pavese, N. (2022). Molecular Imaging of the GABAergic System in Parkinson’s Disease and Atypical Parkinsonisms. Current Neurology and Neuroscience Reports, 22(12), 867-879. https://doi.org/10.1007/s11910-022-01245-z

Taylor-Robinson, S. D., Turjanski, N., Bhattacharya, S., Seery, J. P., Sargentoni, J., Brooks, D. J., Bryant, D. J. & Cox, I. J. (1999). A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metabolic Brain Disease, 14(1), 45-55. https://doi.org/10.1023/A:1020609530444

Taylor-Robinson, S. D., Weeks, R. A., Bryant, D. J., Sargentoni, J., Marcus, C. D., Harding, A. E. & Brooks, D. J. (1996). Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory? Movement Disorders, 11(2), 167-173. https://doi.org/10.1002/mds.870110209

Taylor-Robinson, S. D., Weeks, R. A., Sargentoni, J., Marcus, C. D., Bryant, D., Harding, A. E. & Brooks, D. J. (1994). Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy [23]. Lancet, 343(8906), 1169-1170. https://doi.org/10.1016/S0140-6736(94)90279-8

Taylor, S., Gafton, J., Shah, B., Pagano, G., Chaudhuri, K. R., Brooks, D. J. & Pavese, N. (2016). Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism. Movement Disorders, 31(3), 344-51. https://doi.org/10.1002/mds.26456

Tai, Y. F., Hoshi, R., Brignell, C. M., Cohen, L., Brooks, D. J., Curran, H. V. & Piccini, P. (2011). Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA (ecstasy): An ¹⁸F-dopa PET Study. Neuropsychopharmacology, 36(4), 735-743. https://doi.org/10.1038/npp.2010.201

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J. & Piccini, P. (2007). Imaging microglial activation in Huntington's disease. Brain Research Bulletin, 72(2-3 SPEC. ISS.), 148-151. https://doi.org/10.1016/j.brainresbull.2006.10.029

Tai, Y. F., Ahsan, R. L., De Yébenes, J. G., Pavese, N., Brooks, D. J. & Piccini, P. (2007). Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An ¹⁸F-dopa PET study. Journal of Neural Transmission, 114(3), 337-340. https://doi.org/10.1007/s00702-006-0536-0

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J. & Piccini, P. (2007). Microglial activation in presymptomatic Huntington's disease gene carriers. Brain, 130(7), 1759-1766. https://doi.org/10.1093/brain/awm044

Tai, Y. F., Scherfler, C., Brooks, D. J., Sawamoto, N. & Castiello, U. (2004). The Human Premotor Cortex Is 'Mirror' only for Biological Actions. Current Biology, 14(2), 117-120. https://doi.org/10.1016/j.cub.2004.01.005

Stuart, S., Lawson, R. A., Yarnall, A. J., Nell, J., Alcock, L., Duncan, G. W., Khoo, T. K., Barker, R. A., Rochester, L., Burn, D. J. & ICICLE-PD Study Grp (2019). Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. Movement Disorders, 34(11), 1690-1698. https://doi.org/10.1002/mds.27813

Street, D., Jabbari, E., Costantini, A., Jones, P. S., Holland, N., Rittman, T., Jensen, M. T., Chelban, V., Goh, Y. Y., Guo, T., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Revesz, T., Warner, T. T., Lees, A. J. ... Rowe, J. B. (2023). Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials. Brain, 146(8), 3232-3242. https://doi.org/10.1093/brain/awad105

Strange, P., Møller, A., Ladefoged, O., Lam, H. R., Larsen, J.-J. & Arlien-Søborg, P. (1991). Total number and mean cell volume of neocortical neurons in rats exposed to 2,5-Hexanedione with and without acetone. Neurotoxicology and Teratology, 13, 401-6.

Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D., Pavese, N., Van Eimeren, T., Piccini, P., Politis, M., Thobois, S., Ceravolo, R., Higuchi, M., Kaasinen, V., Masellis, M., Peralta, M. C., Obeso, I., Pineda-Pardo, J. Á., Cilia, R., Ballanger, B., Niethammer, M. ... IPMDS-Neuroimaging Study Group (2017). Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders, 32(2), 181-192. https://doi.org/10.1002/mds.26907

Strafella, A. P., Bohnen, N. I., Pavese, N., Vaillancourt, D. E., van Eimeren, T., Politis, M., Tessitore, A., Ghadery, C., Lewis, S. & IPMDS‐Neuroimaging Study Group (2018). Imaging Markers of Progression in Parkinson's Disease. Movement Disorders Clinical Practice, 5(6), 586-596. https://doi.org/10.1002/mdc3.12673

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2017). Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurology, 16(10), 789-796. https://doi.org/10.1016/S1474-4422(17)30173-4

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Parbo, P., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2018). Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiology of Disease, 115, 9-16. https://doi.org/10.1016/j.nbd.2018.02.017

Stokholm, M. G., Garrido, A., Tolosa, E., Serradell, M., Iranzo, A., Ostergaard, K., Borghammer, P., Moller, A., Parbo, P., Staer, K., Brooks, D. J., Jose Marti, M. & Pavese, N. (2020). Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers. Journal of Neurology, 267(8), 2296-2300. https://doi.org/10.1007/s00415-020-09830-3

Stokholm, K., Thomsen, M. B., Phan, J. A., Møller, L. K., Bay-Richter, C., Christiansen, S. H., Woldbye, D. P. D., Romero-Ramos, M. & Landau, A. M. (2021). α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines, 9(12), Article 1876. https://doi.org/10.3390/biomedicines9121876

Stoessl, A. J., Brooks, D. J. & Eidelberg, D. (2011). Milestones in neuroimaging. Movement Disorders, 26(6), 868-978. https://doi.org/10.1002/mds.23679

Stewart, C. B., Ledingham, D., Foster, V. K., Anderson, K. N., Sathyanarayana, S., Galley, D., Pavese, N. & Pasquini, J. (2023). The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study. Frontiers in Neurology, 14, Article 1155669. https://doi.org/10.3389/fneur.2023.1155669

Steinmüller, J. B., Binda, K. H., Lillethorup, T. P., Søgaard, B., Orlowski, D., Landau, A. M., Bjarkam, C. R., Sørensen, J. C. H. & Glud, A. N. (2022). Quantitative assessment of motor function in minipig models of neurological disorders using a pressure-sensitive gait mat. Journal of Neuroscience Methods, 380, Article 109678. https://doi.org/10.1016/j.jneumeth.2022.109678

Stær, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study. Movement Disorders, 35(S1), S283-S283. https://onlinelibrary.wiley.com/toc/15318257/2020/35/S1

Stær, K., Iranzo, A., Stokholm, M. G., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder. Parkinsonism & Related Disorders, 81, 89-93. https://doi.org/10.1016/j.parkreldis.2020.10.014

Staer, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder. Movement Disorders, 35(Suppl. S1), S283-S283. https://doi.org/10.1002/mds.28268

Staer, K., Iranzo, A., Terkelsen, M. H., Stokholm, M. G., Danielsen, E. H., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2024). Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder. European Journal of Neurology, 31(1), Article e16101. https://doi.org/10.1111/ene.16101

Staer, K., Iranzo, A., Stokholm, M. G., Hvingelby, V. S., Danielsen, E. H., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2024). Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder. Movement Disorders, 39(8), 1323-1328. https://doi.org/10.1002/mds.29767

Sridharan, S., Raffel, J., Nandoskar, A., Record, C., Brooks, D., Owen, D., Sharp, D., Muraro, P., Gunn, R. & Nicholas, R. (2019). Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [ ¹⁸F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Multiple Sclerosis Journal, 21(5), 935-944. https://doi.org/10.1007/s11307-019-01323-8

Sperling, R., Salloway, S., Brooks, D. J., Tampieri, D., Barakos, J., Fox, N. C., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Lieberburg, I., Arrighi, H. M., Morris, K. A., Lu, Y., Liu, E., Gregg, K. M., Brashear, H. R., Kinney, G. G., Black, R. & Grundman, M. (2012). Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurology, 11(3), 241-9. https://doi.org/10.1016/S1474-4422(12)70015-7

Spence, S. A., Hirsch, S. R., Brooks, D. J. & Grasby, P. M. (1998). Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. British Journal of Psychiatry, 172(APR.), 316-323.

Spence, S. A., Brooks, D. J., Hirsch, S. R., Liddle, P. F., Meehan, J. & Grasby, P. M. (1997). A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain, 120(11), 1997-2011. https://doi.org/10.1093/brain/120.11.1997

Speirs, C. J., Navey, F. L., Brooks, D. J. & Impallomeni, M. G. (1986). OPISTHOTONOS AND BENZODIAZEPINE WITHDRAWAL IN THE ELDERLY. The Lancet, 328(8515), 1101. https://doi.org/10.1016/S0140-6736(86)90501-5

Sørensen, J. C. H., Nielsen, M. S., Rosendal, F., Deding, D., Ettrup, K. S. E., Jensen, K. N., Jørgensen, R. L., GLUD, AN., Meier, K., Moberg Fitting, L., Møller, A., Alstrup, A. K. O., Østergaard, L. & Bjarkam, C. R. (2011). Development of neuromodulation treatments in a large animal model: Do neurosurgeons dream of electric pigs? Progress in Brain Research, 194, 97-103. https://doi.org/10.1016/B978-0-444-53815-4.00014-5

Sommerauer, M., Fedorova, T. D., Hansen, A. K., Knudsen, K., Otto, M., Jeppesen, J., Frederiksen, Y., Blicher, J. U., Geday, J., Nahimi, A., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2018). Evaluation of the noradrenergic system in Parkinson's disease; an 11C-MeNER PET and neuromelanin MRI study. Brain, 141(2), 496-504. https://doi.org/10.1093/brain/awx348

Sommerauer, M., Hansen, A. K., Parbo, P., Fedorova, T. D., Knudsen, K., Frederiksen, Y., Nahimi, A., Barbe, M. T., Brooks, D. J. & Borghammer, P. (2018). Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients. Movement Disorders, 33(6), 1006-1010. https://doi.org/10.1002/mds.27411

Smith, R., Wu, K., Hart, T., Loane, C., Brooks, D. J., Bjorklund, A., Odin, P., Piccini, P. & Politis, M. (2015). The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study. Neurobiology of Aging, 36(4), 1736-1742. https://doi.org/10.1016/j.neurobiolaging.2014.12.037

PPMI Sleep Working group on behalf of the PPMI Investigators (2015). Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Movement Disorders, 30(10), 1371-1381. https://doi.org/10.1002/mds.26248

Simonsen, A., Scheel-Krüger, J., Jensen, M., Roepstorff, A., Møller, A., Frith, C. D. & Campbell-Meiklejohn, D. (2014). Serotoninergic effects on judgments and social learning of trustworthiness. Psychopharmacology. https://doi.org/10.1007/s00213-014-3444-2

Sigurdsson, H., Yarnall, A., Galna, B., Lord, S., Alcock, L., Morris, R., Lawson, R., Colloby, S., Firbank, M., Pavese, N., Brooks, D., O'brien, J., Burn, D. & Rochester, L. (2020). Identifying neural signatures of Parkinson's disease that predict decline in gait and postural control. Movement Disorders, 35(Suppl. S1), S281-S282. https://doi.org/10.1002/mds.28268

Sigurdsson, H. P., Yarnall, A. J., Galna, B., Lord, S., Alcock, L., Lawson, R. A., Colloby, S. J., Firbank, M. J., Taylor, J.-P., Pavese, N., Brooks, D. J., O'Brien, J. T., Burn, D. J. & Rochester, L. (2022). Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. Movement Disorders, 37(6), 1222-1234. https://doi.org/10.1002/mds.28977

Sigurdsson, H. P., Alcock, L., Firbank, M., Wilson, R., Brown, P., Maxwell, R., Bennett, E., Pavese, N., Brooks, D. J. & Rochester, L. (2024). Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait. NeuroImage, 288, Article 120531. https://doi.org/10.1016/j.neuroimage.2024.120531

Sharma, J. C., Ross, I. N., Rascol, O. & Brooks, D. (2008). Relationship between weight, levodopa and dyskinesia: The significance of levodopa dose per kilogram body weight. European Journal of Neurology, 15(5), 493-496. https://doi.org/10.1111/j.1468-1331.2008.02106.x

Shakweh, E., Pearce, R. B. & Pavese, N. (2016). Effect of botulinum toxin on the non-motor symptoms of dystonia. Movement Disorders, 31, S566-S566.

Senda, M., Brooks, D. J., Farrar, G., Somer, E. J., Paterson, C. L., Sasaki, M. & McParland, B. J. (2015). The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (F-18) injection in healthy Japanese adult volunteers. Annals of nuclear medicine, 29(7), 627-635. https://doi.org/10.1007/s12149-015-0986-2

Senda, M., Yamamoto, Y., Sasaki, M., Yamane, T., Brooks, D. J., Farrar, G., McParland, B. J. & Heurling, K. (2015). An exploratory efficacy study of the amyloid imaging agent [F-18]flutemetamol in Japanese Subjects. Annals of nuclear medicine, 29(5), 391-399. https://doi.org/10.1007/s12149-015-0957-7

Scott LeBlanc, G., Ramlackhansingh, A. F., Edison, P., Hellyer, P. J., Cole, J., Veronese, M., Leech, R., Greenwood, R. J., Turkheimer, F. E., Gentleman, S. M., Heckemann, R. A., Matthews, P. M., Brooks, D. J. & Sharp, D. J. (2016). Amyloid pathology and axonal injury after brain trauma. Neurology, 86(9), 821-828. https://doi.org/10.1212/WNL.0000000000002413

Schubert, J. J., Veronese, M., Marchitelli, L., Bodini, B., Tonietto, M., Stankoff, B., Brooks, D. J., Bertoldo, A., Edison, P. & Turkheimer, F. E. (2019). Dynamic ¹¹C-PIB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis. Journal of Nuclear Medicine, 60(10), 1452-1460. https://doi.org/10.2967/jnumed.118.223834

Schrag, A., Samuel, M., Caputo, E., Scaravilli, T., Troyer, M., Marsden, C. D., Thomas, D. G. T., Lees, A. J., Brooks, D. J. & Quinn, N. P. (1999). Unilateral pallidotomy for Parkinson's disease: Results after more than 1 year. Journal of Neurology Neurosurgery and Psychiatry, 67(4), 511-517. https://doi.org/10.1136/jnnp.67.4.511

Schrag, A., Rinne, J. O., Burn, D. J., Mathias, C. J., Marsden, C. D., Brooks, D. J. & Quinn, N. P. (1998). Olivopontocerebellar atrophy and multiple system atrophy: Clinical follow-up of 10 patients studied with PET [4]. Annals of Neurology, 44(1), 151-152. https://doi.org/10.1002/ana.410440133

Schrag, A. E., Brooks, D. J., Brunt, E., Fuell, D., Korczyn, A., Poewe, W., Quinn, N. P., Rascol, O. & Stocchi, F. (1998). The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease. Clinical Neuropharmacology, 21(3), 169-175.

Schofield, C., Chaudhuri, K. R., Carroll, C., Sharma, J. C., Pavese, N., Evans, J., Foltynie, T., Reichmann, H., Zurowska, L., Soares-Da-Silva, P. & Lees, A. (2022). Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. Neurodegenerative Disease Management, 12(2), 77-91. https://doi.org/10.2217/nmt-2021-0057

Schmidt, C., Skandali, N., Gleesborg, C., Kvamme, T. L., Schmidt, H., Frisch, K., Møller, A. & Voon, V. (2020). The role of dopaminergic and serotonergic transmission in the processing of primary and monetary reward. Neuropsychopharmacology, 45(9), 1490-1497. https://doi.org/10.1038/s41386-020-0702-3

Schmidt, C., Gleesborg, C., Schmidt, H., Kvamme, T. L., Lund, T. E., Voon, V. & Møller, A. (2021). A bias towards natural rewards away from gambling cues in gamblers under‐going active treatment. Brain Research, 1764, Article 147479. https://doi.org/10.1016/j.brainres.2021.147479

Schmidt, C., Gleesborg, C., Schmidt, H., Kvamme, T. L., Voon, V. & Møller, A. (2023). Neural fingerprints of gambling disorder using diffusion tensor imaging. Psychiatry Research - Neuroimaging, 333, Article 111657. https://doi.org/10.1016/j.pscychresns.2023.111657

Scherfler, C., Khan, N. L., Pavese, N., Lees, A. J., Quinn, N. P., Brooks, D. J. & Piccini, P. P. (2006). Upregulation of dopamine D₂ receptors in dopaminergic drug-naive patients with Parkin gene mutations. Movement Disorders, 21(6), 783-788. https://doi.org/10.1002/mds.20811

Scherfler, C., Khan, N. L., Pavese, N., Eunson, L., Graham, E., Lees, A. J., Quinn, N. P., Wood, N. W., Brooks, D. J. & Piccini, P. P. (2004). Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain, 127(6), 1332-1342. https://doi.org/10.1093/brain/awh150

Sawle, G. V., Playford, E. D., Brooks, D. J., Quinn, N. & Frackowiak, R. S. J. (1993). Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naïve parkinsonism: Diagnostic implications of the d₂ receptor status. Brain, 116(4), 853-867. https://doi.org/10.1093/brain/116.4.853

Sawle, G. V., Brooks, D. J., Marsden, C. D. & Frackowiak, R. S. J. (1991). Corticobasal degeneration: A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain, 114(1), 541-556. https://doi.org/10.1093/brain/114.1.541

Sawle, G. V. & Brooks, D. J. (1990). Positron emission tomography studies of neurotransmitter systems. Journal of Neurology, 237(8), 451-456. https://doi.org/10.1007/BF00314760

Sawamoto, N., Piccini, P., Hotton, G., Pavese, N., Thielemans, K. & Brooks, D. J. (2008). Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain, 131(5), 1294-1302. https://doi.org/10.1093/brain/awn054

Sauerbier, A., Herberg, J., Stopic, V., Loehrer, P. A., Ashkan, K., Rizos, A., Jost, S. T., Schneider, C., Visser-Vandewalle, V., Evans, J., Nimsky, C., Fink, G. R., Antonini, A., Martinez-Martin, P., Silverdale, M., Weintraub, D., Schrag, A., Ray Chaudhuri, K., Timmermann, L. ... EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2024). Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease. npj Parkinson's Disease , 10(1), Article 114. https://doi.org/10.1038/s41531-024-00701-6

Sastre, M., Richardson, J. C., Gentleman, S. M. & Brooks, D. J. (2011). Inflammatory risk factors and pathologies associated with Alzheimer's disease. Current Alzheimer research, 8(2), 132-141. https://doi.org/10.2174/156720511795256062

Samuel, M., Ceballos-Baumann, A. O., Boecker, H. & Brooks, D. J. (2001). Motor imagery in normal subjects and Parkinson's disease patients: An H₂ ¹⁵O PET study. NeuroReport, 12(4), 821-828. https://doi.org/10.1097/00001756-200103260-00040

Samuel, M., Williams, S. C. R., Leigh, P. N., Simmons, A., Chakraborti, S., Andrew, C. M., Fristen, K. J., Goldstein, L. H. & Brooks, D. J. (1998). Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI. Neurology, 51(6), 1567-1575. https://doi.org/10.1212/WNL.51.6.1567

Samuel, M., Caputo, E., Brooks, D. J., Schrag, A., Scaravilli, T., Branston, N. M., Rothwell, J. C., Marsden, C. D., Thomas, D. G. T., Lees, A. J. & Quinn, N. P. (1998). A study of medial pallidotomy for Parkinson's disease: Clinical outcome, MRI location and complications. Brain, 121(1), 59-75. https://doi.org/10.1093/brain/121.1.59

Samuel, M., Ceballos-Baumann, A. O., Blin, J., Uema, T., Boecker, H., Passingham, R. E. & Brooks, D. J. (1997). Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain, 120(6), 963-976. https://doi.org/10.1093/brain/120.6.963

Samuel, M., Ceballos-Baumann, A. O., Turjanski, N., Boecker, H., Gorospe, A., Linazasoro, G., Holmes, A. P., DeLong, M. R., Vitek, J. L., Thomas, D. G. T., Quinn, N. P., Obeso, J. A. & Brooks, D. J. (1997). Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements An H₂ ¹⁵O PET study. Brain, 120(8), 1301-1313. https://doi.org/10.1093/brain/120.8.1301

Salmon, E., Brooks, D. J., Leenders, K. L., Turton, D. R., Hume, S. P., Cremer, J. E., Jones, T. & Frackowiak, R. S. J. (1990). A two-compartment description and kinetic procedure for measuring regional cerebral [¹¹C]nomifensine uptake using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 10(3), 307-316. https://doi.org/10.1038/jcbfm.1990.59

Salmon, E. & Brooks, D. J. (1992). In vivo distribution of catecholamine reuptake sites in human brain gives clues to the physiopathology of MPTP induced Parkinsonism [3]. Journal of Neurology Neurosurgery and Psychiatry, 55(2). https://doi.org/10.1136/jnnp.55.2.167

Sager, T. N., Topp, S., Torup, L., Egestad, B. & Møller, A. (2001). Evaluation of CA1 damage using single-voxel ¹H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Research, 892, 166-175.

Sabers, A., Møller, A., Dam, M., Smed, A., Arlien-Søborg, P., Buchman, J., Andersen, E. B., Boesen, F., Dam, A. M., Lyon, B. B. & Pedersen, B. (1995). Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurologica Scandinavica, 92, 19-27.

Sabers, A., Møller, A., Scheel-Krüger, J. & Dam, A. M. (1996). No loss in total neuron number in the thalamic reticular nucleus and neocortex in the genetic absence epilepsy rats from Strasbourg. Epilepsy Research, 26, 45-48.

Sabers, A., a´Rogvi-Hansen, B., Dam, M., Fischer-Rasmussen, W., Gram, L., Hansen, M., Møller, A. & Winkel, H. (1998). Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurologica Scandinavica, 97, 164-170.

Sabers, A., Bertelsen, F. C. B., Scheel-Krüger, J., Nyengaard, J. R. & Møller, A. (2014). Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism. Neuroscience Letters, 580, 12-6. https://doi.org/10.1016/j.neulet.2014.07.036

Rrapaj, A., Landau, A. M. & Winterdahl, M. (2023). Exploration of possible sex bias in acute social stress research: a semi-systematic review. Acta Neuropsychiatrica, 35(4), 1-29. https://doi.org/10.1017/neu.2023.16

Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A. & Landau, A. (2022). Synaptic Vesicle Glycoprotein 2A: Features and Functions. Frontiers in Neuroscience, 16, Article 864514. https://doi.org/10.3389/fnins.2022.864514

Rossi, R., Bærentzen, S. L., Thomsen, M., Real, C. C., Wegener, G., Grassi-Oliveira, R., Gjedde, A. & Landau, A. (2024). A single dose of cocaine raises SV2A density in hippocampus of adolescent rats. Acta Neuropsychiatrica, 36(2), 109-117. https://doi.org/10.1017/neu.2023.14

Ros, R., Garre, P. G., Hirano, M., Tai, Y. F., Ampuero, I., Vidal, L., Rojo, A., Fontan, A., Vazquez, A., Fanjul, S., Hernandez, J., Cantarero, S., Hoenicka, J., Jones, A., Ahsan, R. L., Pavese, N., Piccini, P., Brooks, D. J., Perez-Tur, J. ... De Yébenes, J. G. (2005). Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Annals of Neurology, 57(5), 634-641. https://doi.org/10.1002/ana.20449

Rønn, L. C. B., Ralets, I., Hartz, B. P., Bech, M., Berezin, A., Berezin, V., Møller, A. & Bock, E. (2000). A simple procedure for quantification of neurite outgrowth based on stereological principles. Journal of Neuroscience Methods, 100, 25-32.

Rømer Thomsen, K., Joensson, M., Lou, H. O. C., Møller, A., Gross, J., Kringelbach, M. L. & Changeux, J.-P. (2013). Altered paralimbic interaction in behavioral addiction. Proceedings of the National Academy of Sciences, 110(12), 4744-9. https://doi.org/10.1073/pnas.1302374110

Rømer Thomsen, K., Fjorback, L., Møller, A. & Lou, H. C. (2014). Applying incentive sensitization models to behavioral addiction. Neuroscience & Biobehavioral Reviews, 45(2014), 343. https://doi.org/10.1016/j.neubiorev.2014.07.009

Rømer Thomsen, K., Callesen, M. B., Linnet, J., Kringelbach, M. L. & Møller, A. (2009). Severity of gambling is Associated with severity of depressive symptoms in pathological gamblers. Behavioural Pharmacology, 20(5-6), 527-36.

Rogers, R. D., Andrews, T. C., Grasby, P. M., Brooks, D. J. & Robbins, T. W. (2000). Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. Journal of Cognitive Neuroscience, 12(1), 142-162. https://doi.org/10.1162/089892900561931

Rodda, J., Okello, A., Edison, P., Dannhauser, T., Brooks, D. J. & Walker, Z. (2010). ¹¹C-PIB PET in subjective cognitive impairment. European Psychiatry, 25(2), 123-125. https://doi.org/10.1016/j.eurpsy.2009.07.011

Rinne, J. O., Brooks, D. J., Rossor, M. N., Fox, N. C., Bullock, R., Klunk, W. E., Mathis, C. A., Blennow, K., Barakos, J., Okello, A. A., de LIano, S. R. M., Liu, E., Koller, M., Gregg, K. M., Schenk, D., Black, R. & Grundman, M. (2010). ¹¹C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. The Lancet Neurology, 9(4), 363-372. https://doi.org/10.1016/S1474-4422(10)70043-0

Ring, H. A., Bench, C. J., Trimble, M. R., Brooks, D. J., Frackowiak, R. S. J. & Dolan, R. J. (1994). Depression in Parkinson's disease. A positron emission study. British Journal of Psychiatry, 165(SEP.), 333-339.

Richardson, M. P., Hammers, A., Brooks, D. J. & Duncan, J. S. (2001). Benzodiazepine-GABA_A receptor binding is very low in dysembryoplastic neuroepithelial tumor: A PET study. Epilepsia, 42(10), 1327-1334. https://doi.org/10.1046/j.1528-1157.2001.44100.x